The temperature-controlled transportation provider will integrate into DHL Supply Chain once the $195 million deal is cleared ...

DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in ...

CRYOPDP is a leading specialty courier providing services for clinical trials, biopharma, and cell & gene therapies.

DHL’s Life Sciences and Healthcare business contributed over EUR 5 billion to global revenue in 2024. The acquisition of CRYOPDP represents a significant move in DHL’s commitment to boost its ...

Headquartered just outside Paris, Cryopdp handles more than 600,000 shipments per year, with customers and patients in over 135 countries. DHL said the acquisition would enhance its capabilities ...

DHL Group already has an established Life Sciences and Healthcare business, contributing over EUR 5 billion in global revenue in 2024. Building on this foundation, the acquisition of CRYOPDP marks ...

DHL Group and Cryoport (CYRX) are pleased to announce that DHL has acquired 100% of Cryopdp, a specialty courier focused on clinical trials, biopharma, and cell and gene therapies. In this context ...